Volume 18, Issue 82 And 83 (4-2011)                   RJMS 2011, 18(82 And 83): 32-43 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nazari H, Modareszadeh S, Soudi R, Maleki A, Mirzajani H. A review article of pharmacologic vitreolysis . RJMS 2011; 18 (82 and 83) :32-43
URL: http://rjms.iums.ac.ir/article-1-1631-en.html
Tehran University of Medical Sciences (TUMS)
Abstract:   (6206 Views)

  Introduction : The vitreoretinal interface is involved in a wide range of vitreoretinal disorders and separation of the posterior vitreous face from the retinal surface is an essential part of vitrectomy surgeries. A diverse range of enzymatic and non-enzymatic agents are being studied as an adjunct before or during vitrectomy to facilitate the induction of posterior vitreous detachment. There is a significant body of knowledge in the literature about different vitreolytic agents under investigation for a variety of pathologies involving the vitreoretinal interface which will be summarized in this review.

  Method s: Articles retrieved by Pubmed search using keywords “Vitreolysis”, pharmacologic Vitreolysis, plasmin and vitrectomy, and microplasmin and vitrectomy, were used in this review.

  Conclusion : recent reports have raised strong hopes that pharmacologic vitreolysis may eventually find its way to clinical practice. Further investigations will demonstrate whether enzymatic vitreolysis could be used as an adjunct and/or alternative treatment for treatment of vitreoretinal disorders.

Full-Text [PDF 430 kb]   (4464 Downloads)    
Type of Study: review article | Subject: Ophthalmology

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Razi Journal of Medical Sciences

Designed & Developed by : Yektaweb